Advertisement
Hosting the call will be Mr. Colin Zhao, Chief Executive Officer, and Mr.Tristan Kuo, Chief Financial Officer.
To participate in the live conference call, please dial the followingnumber five to ten minutes prior to the scheduled conference call time: 866-800-8648. International callers should dial +1-617-614-2702. The pass code forthe call is 874 753 42.
Advertisement
If you are unable to participate in the call at this time, a replay willbe available for 14 days starting on Monday, August 17, 2009 at 11:00 a.m. EDT.To access the replay, dial 888-286-8010, international callers should dial617-801-6888. The conference pass code is 406 925 80.
About China Biologic Products, Inc.
China Biologic Products, Inc. (the "Company"), through its indirectmajority-owned subsidiaries, Shandong Taibang Biological Products Co. Ltd. andChongqing Dalin Biologic Technologies Co., Ltd, and its equity investment inXi'an Huitian Blood Products Co., Ltd., is currently the largest non-state-owned plasma-based biopharmaceutical company approved by the Chinesegovernment. The Company is a fully integrated biologic products company withplasma collection, production and manufacturing, research and development, andcommercial operations. The Company's blood products are irreplaceable duringmedical emergencies, and are used for the prevention and treatment of variousdiseases. It sells its plasma-based biopharmaceutical products to hospitalsand other healthcare facilities in China.For more information, please contact: Company Contact: Mr. Y. Tristan Kuo Chief Financial Officer China Biologic Products, Inc. Tel: +86-538-6202206 Email: [email protected] Web: http://www.chinabiologic.com Investor Relations Contact: Mr. Crocker Coulson, President CCG Investor Relations Tel: +1-646-213-1915 (NY office) or Mr. Gary Chin Tel: +1-646-213-1909 Email: [email protected] Web: http://www.ccgirasia.com
SOURCE China Biologic Products, Inc.
